Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia
Rebekka Wegmann(ETH Zurich), Stefanie Engler(University of Zurich), Marina Bacac(Roche (Switzerland)), Jonas Albinus(SIB Swiss Institute of Bioinformatics), Sujana Sivapatham(University of Zurich), Franziska Singer(SIB Swiss Institute of Bioinformatics), Ricardo Coelho(University of Basel), Bernd Bodenmiller(The Geneva Association), Lars Bosshard(SIB Swiss Institute of Bioinformatics), Natalia Chicherova(University of Zurich), Daniel Baumhoer(University Hospital of Basel), Beatrice Beck‐Schimmer(University of Zurich), Tharshika Thavayogarajah(University Hospital of Zurich), Cinzia Esposito(University of Zurich), Lara Bernasconi(University Hospital of Zurich), Sonali Andani(University of Zurich), Disha Malani(Boston University), Melike Ak(University of Zurich), Niko Beerenwinkel(SIB Swiss Institute of Bioinformatics), Michael Prummer(SIB Swiss Institute of Bioinformatics), Sandra Goetze(ETH Zurich), Jack Kuipers(SIB Swiss Institute of Bioinformatics), Esther Danenberg(University Hospital of Zurich), Ruben Casanova(University of Zurich), Francis Jacob(University of Basel), Per-Olof Attinger(University of Zurich), Gabriele Gut(University of Zurich), Ximena Bonilla(ETH Zurich), Ilaria Alborelli(ETH Zurich), Mattheus H. E. Wildschut(ETH Zurich), Christian Beisel(ETH Zurich), Anne Bertolini(University Hospital of Zurich), Maya D’Costa(SIB Swiss Institute of Bioinformatics), Ulrike Lischetti(University Hospital of Basel), Stéphane Chevrier(University of Zurich), Emanuela S. Milani(Board of the Swiss Federal Institutes of Technology), Julien Mena(ETH Zurich), Natalie R. Davidson(University Hospital of Basel), Nora C. Toussaint(SIB Swiss Institute of Bioinformatics), Jacobo Sarabia del Castillo(University of Zurich), Olivér Vilinovszki(University Hospital of Zurich), Reinhard Dummer(University Hospital of Zurich), Byron Calgua(University Hospital of Basel), Joanna Ficek-Pascual(ETH Zurich), Monica-Andreea Drăgan(University of Zurich), Silvana I. Albert(ETH Zurich), Faisal Alquaddoomi(Roche (Switzerland))
Cited by 25
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
|Nature Methods|2014|2k
The Human Cell Atlas
|Zurich Open Repository and Archive (University of Zurich)|2017|1.6k
Lgr5+ve Stem Cells Drive Self-Renewal in the Stomach and Build Long-Lived Gastric Units In Vitro
|Cell stem cell|2010|1.5k
Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma
|New England Journal of Medicine|2017|1.5k